Genelux Corporation (NASDAQ:GNLX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John Smither Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); MBX Biosciences, Inc. (Chief Financial Officer · Since at least Mar 16, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Applied Molecular Transport Inc (Director · Jan 27, 2022 – Dec 27, 2023 · Past); eFFECTOR Therapeutics Inc (Director · Aug 25, 2020 – Jun 22, 2023 · Past); Arcutis Biotherapeutics, Inc. (Chief Financial Officer · Jan 30, 2020 – Feb 13, 2024 · Past); Principia Biopharma Inc (Director · Feb 19, 2019 – Feb 19, 2019 · Past); Achaogen Inc (Director · Mar 11, 2014 – Jun 5, 2018 · Past); Kythera Biopharmaceuticals Inc (Chief Financial Officer · Oct 10, 2012 – Oct 1, 2015 · Past) | Chair, Compensation Committee · Since at least Sep 11, 2023 |
| James L. Tyree Other companies: Assertio Holdings, Inc. (Director · May 19, 2020 – Mar 14, 2024 · Past); Depomed Inc (Director · Oct 17, 2016 – May 8, 2018 · Past); Innoviva, Inc. (Director · Jun 2, 2014 – Apr 20, 2017 · Past); ChemoCentryx Inc. (Director · Jun 5, 2012 – Oct 20, 2022 · Past); Abbott Laboratories (Executive Vice President · Feb 14, 2006 – Feb 27, 2009 · Past) | Lead Independent Director · Since at least Jan 25, 2023 |
| Doug Samuelson Other companies: Kairos Pharma, Ltd. (Chief Financial Officer · Since at least Sep 16, 2024); Newton Golf Company, Inc. (Chief Financial Officer · Sep 9, 2024 – Sep 9, 2024 · Past) | Vice President, Finance · Jan 25, 2023 – Sep 11, 2023 · Past |
| Eric Groen Other companies: Rani Therapeutics Holdings, Inc. (General Counsel · Mar 22, 2022 – Mar 21, 2024 · Past) | General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development · Since at least Jul 1, 2025 |
| Caroline Jewett | Head of Quality · Jun 30, 2023 – Feb 19, 2024 · Past |
| Gabe Woodward | Director · Jan 25, 2023 – Feb 17, 2023 · Past |
| Jason Litten | Chief Medical Officer · Since at least Jan 2, 2026 |
| John Thomas | Director · Since at least Jan 25, 2023 |
| Joseph Cappello | Chief Technical Officer · Since at least Jan 25, 2023 |
| Lourie S Zak | Chief Financial Officer · Aug 28, 2023 – Dec 18, 2024 · Past |
| Mary Mirabelli | Chair, Nominating and Corporate Governance Committee · Since at least Jan 25, 2023 |
| Matthew Pulisic | Chief Financial Officer · Since at least Jan 30, 2025 |
| Matt Pulisic | Chief Financial Officer · Since at least Jan 12, 2026 |
| Paul Scigalla | Chief Medical Officer · Jan 25, 2023 – Oct 18, 2024 · Past |
| Qian Zhang | Vice President, Clinical Sciences · Since at least Jan 25, 2023 |
| Ralph Smalling | Vice President, Head of Regulatory Affairs · Since at least Jun 30, 2023 |
| Sean Ryder | General Counsel · Jan 25, 2023 – May 12, 2025 · Past |
| Thomas Zindrick | President and Chief Executive Officer · Since at least Jan 25, 2023 |
| Tony Yu | Chief Scientific Officer · Since at least Nov 4, 2026 |
| Yong Yu | Chief Scientific Officer · Since at least Jan 25, 2023 |